Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature

Immune checkpoint inhibitors are antibodies, which enhance cellular and humoral immune responses and are approved for the treatment of various tumors. Immune-related adverse events (irAE) involving different organs and systems are, however, among the side-effects. Recent reports of severe persistent...

Descripción completa

Detalles Bibliográficos
Autores principales: Leitinger, Markus, Varosanec, Mihael V., Pikija, Slaven, Wass, Romana E., Bandke, Dave, Weis, Serge, Studnicka, Michael, Grinzinger, Susanne, McCoy, Mark R., Hauer, Larissa, Sellner, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797606/
https://www.ncbi.nlm.nih.gov/pubmed/29441072
http://dx.doi.org/10.3389/fimmu.2018.00108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797606/
https://www.ncbi.nlm.nih.gov/pubmed/29441072
http://dx.doi.org/10.3389/fimmu.2018.00108

Ejemplares similares